What primary concern does the advisory council address regarding the PDMP?

The primary concern that the advisory council addresses regarding the Prescription Drug Monitoring Program (PDMP) is the safeguards for the release of information. This is crucial because the PDMP collects sensitive data about patients’ prescriptions and medication history. Ensuring that this information is released only to authorized individuals or entities is vital to protect patient privacy and confidentiality. The safeguards set up by the advisory council help to establish protocols and guidelines for when and how this information can be accessed, which is necessary for maintaining public trust in the PDMP system while allowing healthcare professionals to utilize the data to make informed prescribing decisions. This focus on confidentiality and security is critical in preventing misuse of personal health information.